Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver and Intrahepatic Biliary Tract Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01030757
What this trial is testing

Study of Stereotactic Body Radiation Therapy Using Tomotherapy for Metastatic Tumors to the Liver

Who this might be right for
Liver Cancer
New Mexico Cancer Research Alliance 2
Testing effectiveness (Phase 2)Looking for participantsNCT07174570
What this trial is testing

Celecoxib, Durvalumab and Tremelimumab for the Treatment of Patients With Advanced or Metastatic Liver Cancer

Who this might be right for
Advanced Hepatocellular CarcinomaMetastatic Hepatocellular CarcinomaStage III Hepatocellular Carcinoma AJCC v8+1 more
Emory University 39
Testing effectiveness (Phase 2)Ended earlyNCT01020812
What this trial is testing

Combination SBRT With TACE for Unresectable Hepatocellular Carcinoma

Who this might be right for
Carcinoma, HepatocellularHepatobiliary NeoplasmLiver Carcinoma
Stanford University 11
Testing effectiveness (Phase 2)Study completedNCT02821754
What this trial is testing

A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC)

Who this might be right for
Biliary Tract NeoplasmsLiver CancerHepatocellular Carcinoma+2 more
National Cancer Institute (NCI) 54
Not applicableEnded earlyNCT02787954
What this trial is testing

Prospective Tumor Response Evaluation

Who this might be right for
Hepatocellular CancerMetastatic Liver Cancer
The University of Texas Health Science Center, Houston 10
Testing effectiveness (Phase 2)UnknownNCT02862613
What this trial is testing

Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer

Who this might be right for
Precision CellsTranscatheter Arterial ChemoembolizationAdvanced Liver Cancer
Shanghai International Medical Center 40
Large-scale testing (Phase 3)Not Yet RecruitingNCT07537946
What this trial is testing

Local Consolidation After Sintilimab Plus Lenvatinib for Metastatic Liver Cancer

Who this might be right for
Hepatocellular Carcinoma (HCC)Metastases
Tongji Hospital 400
Not applicableEnded earlyNCT04276090
What this trial is testing

Codman Catheter/Synchromed Pump Hepatic Artery Chemotherapy for Unresectable Colorectal Metastases/Intrahepatic Cholangiocarcinoma

Who this might be right for
Bile Duct NeoplasmsColorectal Neoplasms
Michael J Cavnar, MD 21
Not applicableUnknownNCT05369988
What this trial is testing

VALIDATION OF THE VIBe INTRAOPERATIVE BLEEDING SCALE IN LIVER SURGERY

Who this might be right for
Surgical HemorrhageLiver CancerLiver Metastases
Hospital Miguel Servet 259
Early research (Phase 1)Study completedNCT03674073
What this trial is testing

A Study Combining Personalized Neoantigen-based Dendritic Cell Vaccine With Microwave Ablation for the Treatment of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver Cancer, Adult
Chinese PLA General Hospital 24
Testing effectiveness (Phase 2)Study completedNCT01853618
What this trial is testing

Tremelimumab With Chemoembolization or Ablation for Liver Cancer

Who this might be right for
Heptocellular CancerBiliary Tract NeoplasmsLiver Cancer+2 more
National Cancer Institute (NCI) 61
Testing effectiveness (Phase 2)Study completedNCT00627042
What this trial is testing

Study of IMC-1121B (Ramucirumab) in Participants With Liver Cancer Who Have Not Previously Been Treated With Chemotherapy

Who this might be right for
Hepatocellular Carcinoma
Eli Lilly and Company 42
Testing effectiveness (Phase 2)Ended earlyNCT04805788
What this trial is testing

Stereotactic Body Proton Radiotherapy for the Treatment of Liver Cancer

Who this might be right for
Recurrent Hepatocellular CarcinomaStage I Hepatocellular Carcinoma AJCC v8Stage II Hepatocellular Carcinoma AJCC v8+1 more
Mayo Clinic 9
Not applicableEnded earlyNCT05342350
What this trial is testing

International Study of High-Risk Patients for Hepatocellular Carcinoma Using Liquid Biopsy

Who this might be right for
Liver CancerLiver CirrhosisHepatocellular Carcinoma+1 more
Johns Hopkins University 360
Large-scale testing (Phase 3)Active Not RecruitingNCT02523443
What this trial is testing

Patient Controlled Epidural Analgesia Versus Intravenous Patient Controlled Analgesia for Post-Operative Pain Control in Patients Undergoing Elective Liver Resection

Who this might be right for
Liver CancerPain Management
Memorial Sloan Kettering Cancer Center 231
Early research (Phase 1)Study completedNCT00581815
What this trial is testing

Spectroscopy With Surface Coils and Decoupling

Who this might be right for
Adrenal Cortical CancerBrain CancerBreast Cancer+16 more
Memorial Sloan Kettering Cancer Center 582
Early research (Phase 1)Study completedNCT00303940
What this trial is testing

Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorKidney Cancer+5 more
National Institutes of Health Clinical Center (CC) 26
Testing effectiveness (Phase 2)Study completedNCT00002608
What this trial is testing

Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors

Who this might be right for
Adrenocortical CarcinomaBrain and Central Nervous System TumorsHead and Neck Cancer+4 more
Ottawa Regional Cancer Centre 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07260058
What this trial is testing

Immune Cell Therapy for Advanced Solid Tumors

Who this might be right for
Lung Cancer (Locally Advanced or Metastatic)Liver Cancer (Locally Advanced or Metastatic)Colorectal Cancer (Locally Advanced or Metastatic)+2 more
Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd. 48
Early research (Phase 1)Study completedNCT01498952
What this trial is testing

MEDI-573 in Combination With SOC in Unresectable or Metastatic HCC.

Who this might be right for
Unresectable or Metastatic Hepatocellular Carcinoma (HCC)
MedImmune LLC 6
Next Page